EYPT EyePoint Pharmaceuticals Net earnings per share (EPS TTM)

EYPT (EyePoint Pharmaceuticals) - company brandmark

EyePoint Pharmaceuticals management strictly adheres to environmental regulations regarding reagent disposal. The 12-month net income per share trend on GURU.Markets captures the results of developing sustained-release drug delivery systems and expanding a network of specialized laboratories to maintain margins. The current -3.76 metric reflects the efficiency dynamics of these proprietary technologies and supply chains.

EYPT EyePoint Corp Net earnings per share for the last four quarters (07/04/2022 - 11/11/2026)

Analytical breakdowns and data insights for company EyePoint Pharmaceuticals Inc (EYPT)

- share price and expert price forecast:
Stock Quotes EyePoint Pharmaceuticals|EYPT - Average Forecast Price
- market capitalization data:
Market Capitalization EyePoint Pharmaceuticals, Inc.|EYPT - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share EyePoint Pharmaceuticals|EYPT - Book Valuation of Business|Market Capitalization to Book Value Ratio eyepointpharma.com|EYPT - Company Assets
- debt and liquidity details:
Total Debt to Equity Ratio EyePoint Pharmaceuticals|EYPT - Long-Term Liabilities to Capital|Short-Term Debt to Capital EyePoint Pharma|EYPT - Company Cumulative Debt|Debt to Book Capitalization Ratio EyePoint Pharmaceuticals, Inc.|EYPT - Long-Term Liabilities|Company Short-Term Debt EyePoint Pharmaceuticals|Quick Ratio eyepointpharma.com
- earnings and multiples data:
EYPT - Net Financial Result|Expected Profit EyePoint Pharmaceuticals|EYPT - Price to Earnings Multiple|Projected Price to Earnings EyePoint Pharmaceuticals, Inc.|EYPT - Company Value to Earnings Growth Ratio|Enterprise Value to EBITDA Ratio EyePoint Pharmaceuticals, Inc.|EYPT - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months EyePoint Pharmaceuticals|EYPT - Earnings per one share for the last 12 months|Quarterly EPS earnings growth eyepointpharma.com|EYPT - Earnings per share increase in current year|Earnings growth forecast for next year EyePoint Pharmaceuticals
Basic company analysis:EYPT - EyePoint Pharmaceuticals
Flagship merchandise of EyePoint Pharmaceuticals Inc

This metric reflects the net income of EyePoint Pharmaceuticals (EYPT) allocated per common share over the last twelve months, allowing for an assessment of the business's real profitability without accounting for capital dilution. By analyzing the trailing twelve-month earnings per share, an investor can gauge the efficiency of the commercialization of ophthalmologic implants under the guidance of experienced experts, where the stability of the metric confirms the resilience of the market entry strategy for its drugs.

Key competitors

ALC: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months bausch.com|GKOS: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Apellis Pharmaceuticals, Inc. (APLS)|Earnings per share for the last twelve months Belite Bio, Inc|Ocular Pharma (OCUL) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) HROW|VRDN - Net earnings per one share for the last twelve months|LENZ Therapeutics - Net earnings per share for the last 12 months|Oculis AG (OCS) - Net earnings per one share for the last twelve months|Kodiak Pharma - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Aldeyra Therapeutics|kalarx.com (KALA) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months IRD (Opus Genetics)|Earnings per share for the last twelve months OKYO Pharma Ltd|Net earnings per one share for the last twelve months Adverum ADVM|Net earnings per share (EPS TTM) OTLK|Net earnings per share for the last four quarters Clearside Corp|Earnings per share for the last twelve months NovaBay Pharmaceuticals, Inc. NBY|KPRX: Earnings per share for the last 12 months|ALIM: Net earnings per share for the last 12 months|Eyenovia, Inc. - Earnings per share for the last four quarters|GHSI (Guardion Health Sciences Inc.) - Net earnings per share for the last 12 months|Ocuphire Corporation - Earnings per share for the trailing year|Earnings per share for the last twelve months Opthea Limited